Caligan Partners LP - 06 May 2022 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role: 10%+ Owner
Signature: Caligan Partners LP, By: /s/ David Edward Johnson, Partner
Issuer symbol: LAB
Transactions as of: 06 May 2022
Net transactions value: +$1,406,715
Form type: 4
Filing time: 10 May 2022, 21:03:03 UTC
Previous filing: 02 May 2022
Next filing: 19 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LAB	Common Stock, $0.001 par value per share (Common Stock)	Purchase	$1,343,715	+463,350	+4.9%	$2.90	9,948,188	06 May 2022	See footnote	F1, F2
transaction	LAB	Common Stock	Purchase	$63,000	+25,000	+0.25%	$2.52	9,973,188	10 May 2022	See footnote	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The securities reported herein are held by an affiliated fund and managed account of Caligan Partners LP ("Caligan"). David Johnson (together with Caligan, the "Reporting Persons") is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.
F2	The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price.

Remarks:

The Reporting Persons disclaim beneficial ownership in the securities reported on this Form 4 except to the extent of his or its pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that any of the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 or for any other purpose.